460 related articles for article (PubMed ID: 17132902)
1. Epigenetic diagnostics of cancer--the application of DNA methylation markers.
Paluszczak J; Baer-Dubowska W
J Appl Genet; 2006; 47(4):365-75. PubMed ID: 17132902
[TBL] [Abstract][Full Text] [Related]
2. Early Epigenetic Markers for Precision Medicine.
Dumitrescu RG
Methods Mol Biol; 2018; 1856():3-17. PubMed ID: 30178243
[TBL] [Abstract][Full Text] [Related]
3. Analysis of DNA Methylation Status in Bodily Fluids for Early Detection of Cancer.
Yokoi K; Yamashita K; Watanabe M
Int J Mol Sci; 2017 Mar; 18(4):. PubMed ID: 28358330
[TBL] [Abstract][Full Text] [Related]
4. DNA methylation based biomarkers in colorectal cancer: A systematic review.
Lam K; Pan K; Linnekamp JF; Medema JP; Kandimalla R
Biochim Biophys Acta; 2016 Aug; 1866(1):106-20. PubMed ID: 27385266
[TBL] [Abstract][Full Text] [Related]
5. Genetic and epigenetic biomarkers in cancer : improving diagnosis, risk assessment, and disease stratification.
Verma M; Seminara D; Arena FJ; John C; Iwamoto K; Hartmuller V
Mol Diagn Ther; 2006; 10(1):1-15. PubMed ID: 16646573
[TBL] [Abstract][Full Text] [Related]
6. Significance of aberrant DNA methylation for cancer diagnostics and therapy.
Urban T; Pokorná P; Slabý O
Klin Onkol; 2024; 38(2):88-94. PubMed ID: 38697816
[TBL] [Abstract][Full Text] [Related]
7. DNA methylation and Cancer: Identifying and targeting epigenetic modifications may be the future of cancer therapy?
Maresca G; Wismayer PS
Gulf J Oncolog; 2016 May; 1(21):77-83. PubMed ID: 27250895
[TBL] [Abstract][Full Text] [Related]
8. Hypermethylation of ITGA4, TFPI2 and VIMENTIN promoters is increased in inflamed colon tissue: putative risk markers for colitis-associated cancer.
Gerecke C; Scholtka B; Löwenstein Y; Fait I; Gottschalk U; Rogoll D; Melcher R; Kleuser B
J Cancer Res Clin Oncol; 2015 Dec; 141(12):2097-107. PubMed ID: 25902909
[TBL] [Abstract][Full Text] [Related]
9. DNA methylation markers in colorectal cancer.
Kim MS; Lee J; Sidransky D
Cancer Metastasis Rev; 2010 Mar; 29(1):181-206. PubMed ID: 20135198
[TBL] [Abstract][Full Text] [Related]
10. PCR-based methods for detecting single-locus DNA methylation biomarkers in cancer diagnostics, prognostics, and response to treatment.
Kristensen LS; Hansen LL
Clin Chem; 2009 Aug; 55(8):1471-83. PubMed ID: 19520761
[TBL] [Abstract][Full Text] [Related]
11. DNA methylation in cancer: a gene silencing mechanism and the clinical potential of its biomarkers.
Fukushige S; Horii A
Tohoku J Exp Med; 2013 Mar; 229(3):173-85. PubMed ID: 23419314
[TBL] [Abstract][Full Text] [Related]
12. Molecular diagnostic applications of DNA methylation technology.
Cottrell SE
Clin Biochem; 2004 Jul; 37(7):595-604. PubMed ID: 15234241
[TBL] [Abstract][Full Text] [Related]
13. The Role of DNA Methylation in Cancer.
Lakshminarasimhan R; Liang G
Adv Exp Med Biol; 2016; 945():151-172. PubMed ID: 27826838
[TBL] [Abstract][Full Text] [Related]
14. ROS-mediated DNA methylation pattern alterations in carcinogenesis.
Wu Q; Ni X
Curr Drug Targets; 2015; 16(1):13-9. PubMed ID: 25585126
[TBL] [Abstract][Full Text] [Related]
15. Promoter hypermethylation of tumour suppressor genes as potential biomarkers in colorectal cancer.
Ng JM; Yu J
Int J Mol Sci; 2015 Jan; 16(2):2472-96. PubMed ID: 25622259
[TBL] [Abstract][Full Text] [Related]
16. Promoter hypermethylation of the 14-3-3 sigma, SYK and CAGE-1 genes is related to the various phenotypes of urinary bladder carcinomas and associated with progression of transitional cell carcinomas.
Kunze E; Wendt M; Schlott T
Int J Mol Med; 2006 Oct; 18(4):547-57. PubMed ID: 16964403
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic alterations by methylation of RASSF1A and DAPK1 promoter sequences in mammary carcinoma detected in extracellular tumor DNA.
Ahmed IA; Pusch CM; Hamed T; Rashad H; Idris A; El-Fadle AA; Blin N
Cancer Genet Cytogenet; 2010 Jun; 199(2):96-100. PubMed ID: 20471512
[TBL] [Abstract][Full Text] [Related]
18. Early Insights into Cancer Epigenetics: Gene Promoter Hypermethylation Emerges as a Potential Biomarker for Cancer Detection.
Clark SJ; Molloy PL
Cancer Res; 2022 Apr; 82(8):1461-1463. PubMed ID: 35425958
[TBL] [Abstract][Full Text] [Related]
19. Inflammation-related aberrant patterns of DNA methylation: detection and role in epigenetic deregulation of cancer cell transcriptome.
Suzuki H; Toyota M; Kondo Y; Shinomura Y
Methods Mol Biol; 2009; 512():55-69. PubMed ID: 19347273
[TBL] [Abstract][Full Text] [Related]
20. [Epigenome and cancer: new possibilities of cancer prevention and therapy?].
Paluszczak J; Baer-Dubowska W
Postepy Biochem; 2005; 51(3):244-50. PubMed ID: 16381168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
